DAY 2 - Sunday, April 27
OPENING GENERAL SESSION
Binkhorst Lecture: Right time for MIGS
Interventional glaucoma is the new horizon for patients. Microinvasive glaucoma surgery (MIGS)—a term coined by Iqbal Ike K. Ahmed, MD—will allow for early intervention in patients with glaucoma and be safe and more effective than the medications and laser procedures used for so long with less efficacy.» MORE
|
|
ADVERTISEMENT
"More profit from my optical dispensary? I liked the sound of that."
"Vision Associates put in place a customized, turnkey program that increased my profits over 50% and dramatically decreased my workload. I maintained ownership/control; they did the rest."
Dr. John Haines - Owner, The Eye Center, Eugene OR. ASCRS Booth #1511.
 visassoc.com
|
|
SURGERY
Survey captures snapshot of astigmatism
The 2013 ASCRS Clinical Survey Results on Astigmatism—covering 168 data points with more than 1,000 physicians responding—showed that 57% of physicians saw benefits associated with femtosecond laser arcuate incisions compared with conventional manual incisions, according to John A. Vukich, MD. » MORE
|
|
Scleral implant improves near vision
The preliminary results of the FDA multicenter trial of the Refocus Scleral Implant (Refocus Group) for presbyopia indicated that patients had a significant increase in the near visual acuity, and that the visual acuity improved over time, according to David Schanzlin, MD. » MORE
|
|
Anterior chamber phakic IOL for high myopia
The hydrophobic, acrylic, anterior chamber phakic IOL (AcrySof Cachet, Alcon Laboratories) performed well in a 5-year study of its safety and efficacy, according to Thomas Kohnen, MD, PhD. Most importantly, he said, the decrease in the corneal endothelial cell count was low and there were low rates of serious adverse events. » MORE
|
|
FROM THE SHOW FLOOR
CCH procedure reduces inflammation
Bio-Tissue Inc. introduced a new procedure for conjunctivochalasis—the reservoir restoration procedure for conjunctivochalasis (CCH) dry eye.» MORE
|
|
Alphaeon launches interactive software
Alphaeon Corp. launches an innovative ophthalmology practice development platform (TouchMD) that helps specialty physicians engage patients in the education process before, during, and after the consultation.» MORE
|
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
| |
|
 Top Tweets
|
|
We welcome your feedback!
Please send your comments to:
Mark L. Dlugoss
Group Content Director
Advanstar Eye Health Group
mdlugoss@advanstar.com |
|
|
